⌘K

Login Start Free

Home/Filings/4/0001654954-23-003749

4//SEC Filing

Perlysky Dov 4

Accession 0001654954-23-003749

CIK 0001304161other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 7:23 PM ET

Size

14.8 KB

Accession

0001654954-23-003749

Insider Transaction Report

Form 4

Period: 2023-03-24

Pharma-Bio Serv, Inc.PBSV

Director

Transactions

Exercise/Conversion
Stock Option
2023-03-24−20,000→ 0 total
Exercise: $0.76Exp: 2025-01-10→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock
2023-03-24$1.00/sh+20,000$20,000→ 64,288 total
Tax Payment
Common Stock
2023-03-24$1.17/sh−12,991$15,199→ 54,203 total
Exercise/Conversion
Stock Option
2023-03-24−20,000→ 0 total
Exercise: $1.00Exp: 2024-01-10→ Common Stock (20,000 underlying)
Tax Payment
Common Stock
2023-03-24$1.17/sh−17,094$20,000→ 47,194 total
Exercise/Conversion
Common Stock
2023-03-24$0.76/sh+20,000$15,200→ 67,194 total

Holdings

Common Stock
(indirect: By Spouse)
772,791
Common Stock
(indirect: Managing Member)
1,164,554

Footnotes (5)

[F1]Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
[F2]The Reporting Person is the Managing Member of Krovim LLC, which owns the 1,164,554 shares of common stock reported herein.
[F3]The Reporting Person's wife is the Managing Member of LDP Family Partnership, which owns the 772,791 shares of common stock, of which the Reporting Person disclaims beneficial ownership.
[F4]The option vested in two equal installments on July 10, 2019 and July 10, 2020.
[F5]The option vested in two equal installments on July 10, 2020 and July 10, 2021.

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Pharma-Bio Serv, Inc.

CIK 0001304161

Entity typeother

Related Parties

1

filerCIK 0001072922

Filing Metadata

Form type: 4
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 7:23 PM ET
Size: 14.8 KB

View on SEC.gov